ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      58,706.59
      1.41%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Leap Therapeutics Inc (LPTX)

      7. Leap Therapeutics Inc (LPTX) News

      LPTX

      Leap Therapeutics (LPTX)

      Leap Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:LPTX
      DateTimeSourceHeadlineSymbolCompany
      02/26/20207:00AMPR Newswire (US)Leap Therapeutics to Present at Cowen 40th Annual Health Care ConferenceNASDAQ:LPTXLeap Therapeutics Inc
      02/13/20204:47PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:LPTXLeap Therapeutics Inc
      02/10/20209:16AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:LPTXLeap Therapeutics Inc
      02/07/202011:26AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:LPTXLeap Therapeutics Inc
      02/04/20207:00AMPR Newswire (US)Leap Therapeutics to Present at 22nd Annual BIO CEO & Investor ConferenceNASDAQ:LPTXLeap Therapeutics Inc
      01/28/20205:18PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:LPTXLeap Therapeutics Inc
      01/23/20207:00AMPR Newswire (US)Leap Therapeutics Presents Updated Data at the ASCO 2020 Gastrointestinal Cancers Symposium (ASCO GI) Global MeetingNASDAQ:LPTXLeap Therapeutics Inc
      01/21/20205:04PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:LPTXLeap Therapeutics Inc
      01/07/20205:19PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LPTXLeap Therapeutics Inc
      01/07/20204:05PMPR Newswire (US)Leap Therapeutics Announces Closing of Previously Announced Equity FinancingNASDAQ:LPTXLeap Therapeutics Inc
      01/03/202011:12AMDow Jones NewsLeap Therapeutics Shares Jump 56% After Deal With BeiGeneNASDAQ:LPTXLeap Therapeutics Inc
      01/03/20209:38AMDow Jones NewsLeap Therapeutics Shares Up 62% Premarket on BeiGene DealNASDAQ:LPTXLeap Therapeutics Inc
      01/03/20209:11AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LPTXLeap Therapeutics Inc
      01/03/20208:53AMPR Newswire (US)Leap Therapeutics and BeiGene Announce Exclusive Option and License Agreement for DKN-01 and Leap Announces $27 Million Equit...NASDAQ:LPTXLeap Therapeutics Inc
      11/22/20194:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LPTXLeap Therapeutics Inc
      11/14/20197:16AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LPTXLeap Therapeutics Inc
      11/14/20197:00AMPR Newswire (US)Leap Therapeutics Reports Third Quarter 2019 Financial ResultsNASDAQ:LPTXLeap Therapeutics Inc
      11/14/20196:52AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:LPTXLeap Therapeutics Inc
      09/17/20197:16AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LPTXLeap Therapeutics Inc
      09/17/20197:00AMPR Newswire (US)Leap Therapeutics to Present Updated Data for DKN-01 Monotherapy and Paclitaxel Combination at the 2019 International Gynecol...NASDAQ:LPTXLeap Therapeutics Inc
      09/04/20197:02AMPR Newswire (US)Leap Therapeutics to Present at Upcoming Investor ConferencesNASDAQ:LPTXLeap Therapeutics Inc
      08/13/20196:02AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:LPTXLeap Therapeutics Inc
      08/09/20197:12AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LPTXLeap Therapeutics Inc
      08/09/20197:00AMPR Newswire (US)Leap Therapeutics Reports Second Quarter 2019 Financial ResultsNASDAQ:LPTXLeap Therapeutics Inc
      08/09/20196:53AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:LPTXLeap Therapeutics Inc
      08/09/20196:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:LPTXLeap Therapeutics Inc
      08/06/20197:16AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LPTXLeap Therapeutics Inc
      08/06/20197:00AMPR Newswire (US)Leap Presents Positive Clinical Results for the Combination of DKN-01 plus Keytruda® and Provides DKN-01 Program UpdateNASDAQ:LPTXLeap Therapeutics Inc
      07/31/20195:26PMEdgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:LPTXLeap Therapeutics Inc
      07/25/20197:00AMPR Newswire (US)Leap Therapeutics to Host Conference Call to Provide DKN-01 Program UpdateNASDAQ:LPTXLeap Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:LPTX

      Your Recent History

      BIT
      F29039
      Vontobel Financial Produ...
      BIT
      UC4AZ7
      Unicredit Bank
      Delayed Upgrade Clock